Key Points - Key clinical catalysts are ahead for Karyopharm, including FDA engagement and publication plans for its Phase 3 SENTRY myelofibrosis trial, plus an expected mid-2026 readout from the endometrial cancer study XPORT-EC-042. - The SENTRY trial showed a statistically...<
Key Points - Kolibri Global Energy posted what management called its strongest quarter ever, with record first-quarter production of 4,685 BOE/day, net revenue of $19.6 million, and adjusted EBITDA of $14.8 million. - The company continued to strengthen its balance sheet:...
Key Points - Q1 earnings weakened as net investment income fell to $0.38 per share from $0.45, while NAV dropped to $18.27 from $19.10. Management said higher non-accruals, lower base rates, and credit-market volatility were the main pressures. - Crescent raised its non-ac
Cerebras (CBRS) IPO started trading at $385. The IPO price was set at $185 raising $5.5B at the IPO price Investor in at the IPO price are already up 108.11%. Cerebras is an AI chip designer that competes with Nvidia, known for its Wafer-Scale Engine (WSE) — a singl
SUNS management highlights opportunities in 2021-2022 vintage bridge loans amid sector bifurcation and capital recycling. Sunrise Realty Trust reported Q1 2026 performance driven by capital recycling, including a Colorado bridge loan and Dallas multifamily payoff. The firm
Bloom Energy (NYSE: BE) is a clean energy company making large, box-shaped power generators that let businesses generate their own electricity instead of buying it from the grid. It essentially gives companies their own mini power plant that keeps the lights on even if the
Coinbase, MicroStrategy, and Marathon Digital rise as traders anticipate Senate Banking Committee approval of regulatory clarity legislation. Shares of Coinbase Global jumped 10% to $222 after the Senate Banking Committee moved closer to approving the Digital Asset Market
The company forecasts record earnings for the first half of 2026 amid geopolitical tensions in the Persian Gulf. Okeanis Eco Tankers expects to secure approximately $202,900 per day in fixed rates for Q2 2026, citing uncertainty around the Strait of Hormuz. The projection
Quick Read - CVS Health (CVS) posted Q1 adjusted EPS of $2.57, beating consensus by 36%, while Aetna’s health benefits operating income surged 52.6% as the medical benefit ratio improved to 84.6% from 87.3%. - Management raised full-year adjusted EPS guidance to $7.30-$7.50 and...</strong
Arista Networks reported Q2 2026 revenue of $2.71 billion, up 35.1% year-over-year, prompting Truist to raise its price target. Arista Networks posted Q2 2026 revenue of $2.71 billion, a 35.1% year-over-year increase and 8.9% sequential growth, driven by demand for cloud n